A single-arm, open-label, Phase 2 study evaluating A single-arm, open-label, Phase 2 study evaluating by an On Body Delivery System, in combination with weekly carfilzomib and dexamethasone in adult participants with relapsed and/or refractory multiple myeloma (RRMM)
A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
MASTER SCREENING STUDY TO DETERMINE INDIVIDUALS WITH POTENTIAL TRIAL ELIGIBILITY FOR ALZHEIMER’S DISEASE STUDIES AS ASSESSED BY BIOMARKER STATUS AND COGNITION
A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY OF TRONTINEMAB IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE(MCI TO MILD DEMENTIA DUE TO AD)